| Literature DB >> 32516135 |
Jialing Yu1,2,3,4, Xiaoyang Liang2,3, Yanchun Ji1,2,3, Cheng Ai2,3, Junxia Liu2,3, Ling Zhu1,2,3, Zhipeng Nie2,3, Xiaofen Jin2,3,4, Chenghui Wang2,3, Juanjuan Zhang2,5, Fuxin Zhao5, Shuang Mei2,3, Xiaoxu Zhao1,2,3, Xiangtian Zhou5, Minglian Zhang6, Meng Wang1,2,3, Taosheng Huang7, Pingping Jiang1,2,3, Min-Xin Guan1,2,3,4,8.
Abstract
Leber's hereditary optic neuropathy (LHON) is a maternally inherited eye disease. X-linked nuclear modifiers were proposed to modify the phenotypic manifestation of LHON-associated mitochondrial DNA (mtDNA) mutations. By whole-exome sequencing, we identified the X-linked LHON modifier (c.157C>T, p.Arg53Trp) in PRICKLE3 encoding a mitochondrial protein linked to biogenesis of ATPase in 3 Chinese families. All affected individuals carried both ND4 11778G>A and p.Arg53Trp mutations, while subjects bearing only a single mutation exhibited normal vision. The cells carrying the p.Arg53Trp mutation exhibited defective assembly, stability, and function of ATP synthase, verified by PRICKLE3-knockdown cells. Coimmunoprecipitation indicated the direct interaction of PRICKLE3 with ATP synthase via ATP8. Strikingly, cells bearing both p.Arg53Trp and m.11778G>A mutations displayed greater mitochondrial dysfunction than those carrying only a single mutation. This finding indicated that the p.Arg53Trp mutation acted in synergy with the m.11778G>A mutation and deteriorated mitochondrial dysfunctions necessary for the expression of LHON. Furthermore, we demonstrated that Prickle3-deficient mice exhibited pronounced ATPase deficiencies. Prickle3-knockout mice recapitulated LHON phenotypes with retinal deficiencies, including degeneration of retinal ganglion cells and abnormal vasculature. Our findings provided new insights into the pathophysiology of LHON that were manifested by interaction between mtDNA mutations and X-linked nuclear modifiers.Entities:
Keywords: Genetic diseases; Genetics; Mitochondria; Molecular pathology; Ophthalmology
Mesh:
Substances:
Year: 2020 PMID: 32516135 PMCID: PMC7456240 DOI: 10.1172/JCI134965
Source DB: PubMed Journal: J Clin Invest ISSN: 0021-9738 Impact factor: 14.808